The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Tissue-Specific Role of Glycogen Synthase Kinase 3β in Glucose Homeostasis and Insulin Action
Open accessAbstract
Dysregulation of the protein kinase glycogen synthase kinase 3 (GSK-3) has been implicated in the development of type 2 diabetes mellitus. GSK-3 protein expression and kinase activity are elevated in diabetes, while selective GSK-3 inhibitors have shown promise as modulators of glucose metabolism and insulin sensitivity. There are two GSK-3 isoforms in mammals, GSK-3alpha and GSK-3beta. Mice engineered to lack GSK-3beta die in late embryogenesis from liver apoptosis, whereas mice engineered to lack GSK-3alpha are viable and exhibit improved insulin sensitivity and hepatic glucose homeostasis. To assess the potential role of GSK-3beta in insulin function, a conditional gene-targeting approach whereby mice in which expression of GSK-3beta was specifically ablated within insulin-sensitive tissues were generated was undertaken. Liver-specific GSK-3beta knockout mice are viable and glucose and insulin tolerant and display "normal" metabolic characteristics and insulin signaling. Mice lacking expression of GSK-3beta in skeletal muscle are also viable but, in contrast to the liver-deleted animals, display improved glucose tolerance that is coupled with enhanced insulin-stimulated glycogen synthase regulation and glycogen deposition. These data indicate that there are not only distinct roles for GSK-3alpha and GSK-3beta within the adult but also tissue-specific phenotypes associated with each of these isoforms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Self-citationMolecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Self-citationPostic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
Thomas, J. A., Schlender, K. K., & Larner, J. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90127-9 · Cited by 1,199
Embi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Sutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903 · cited 2×
“GSK-3 is highly active under resting conditions and is rapidly inactivated by insulin through phosphorylation of an N-terminal domain serine residue (Ser 21 of GSK-3 and Ser 9 of GSK-3 ) (43).”
Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00025-9 · Cited by 897
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., & Mills, G. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413597 · Cited by 830
Self-citationEtiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 1×
“A major feature of type 2 diabetes mellitus (T2DM) is impairment of both basal and insulin-stimulated glucose metabolism in insulin-responsive, peripheral tissues, including skeletal muscle (SM) and liver (2, 37, 41).”
BackgroundEMBI, N., RYLATT, D. B., & COHEN, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06059.x · Cited by 779
Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600633 · Cited by 594
Ring, D. B., Johnson, K. W., Henriksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Ma, S. T., Reeder, J. W., Samuels, I., Slabiak, T., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.588 · Cited by 532
Doble, B. W., Patel, S., Wood, G. A., Kockeritz, L. K., & Woodgett, J. R. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.001 · Cited by 448
Self-citationInhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to Lithium
Zhang, F., Phiel, C. J., Spece, L., Gurvich, N., & Klein, P. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212635200 · Cited by 435
Specific features of glycogen metabolism in the liver
BOLLEN, M., KEPPENS, S., & STALMANS, W. (1998) · Biochemical Journal · doi:10.1042/bj3360019 · Cited by 409
DeFronzo, R. A. (1981) · Diabetes Care · doi:10.2337/diacare.4.4.493 · Cited by 389
DNA excision in liver by an albumin-Cre transgene occurs progressively with age
Postic, C., & Magnuson, M. A. (2000) · genesis · doi:10.1002/(sici)1526-968x(200002)26:2<149::aid-gene16>3.0.co;2-v · Cited by 369
Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Mohideen, P., Carter, L., & Henry, R. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.263 · Cited by 357
Bondar, R. J. L., & Mead, D. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.5.586 · Cited by 357
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Bouché, C., Serdy, S., Kahn, C. R., & Goldfine, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0026 · Cited by 346
New Insights Into the Role and Mechanism of Glycogen Synthase Activation by Insulin
Lawrence, J. C., & Roach, P. J. (1997) · Diabetes · doi:10.2337/diab.46.4.541 · Cited by 311 · cited 1×
“In the absence of insulin, active GSK-3 phosphorylates four serine residues in the C-terminal domain of GS and negatively regulates its activity, reducing the capacity of cells to synthesize and store glycogen (25).”
BackgroundS6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of Akt
Zhang, H. H., Lipovsky, A. I., Dibble, C. C., Sahin, M., & Manning, B. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.09.019 · Cited by 308
Glycogen Synthase Kinase 3α-Specific Regulation of Murine Hepatic Glycogen Metabolism
MacAulay, K., Doble, B. W., Patel, S., Hansotia, T., Sinclair, E. M., Drucker, D. J., Nagy, A., & Woodgett, J. R. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.013 · Cited by 299
Self-citationPARKER, P. J., CAUDWELL, F. B., & COHEN, P. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07140.x · Cited by 298
Rylatt, D. B., Aitken, A., Bilham, T., Condon, G. D., Embi, N., & Cohen, P. (1980) · PubMed · Cited by 285
Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.
Eldar-Finkelman, H., Schreyer, S. A., Shinohara, M. M., LeBoeuf, R. C., & Krebs, E. G. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1662 · Cited by 252
Muscle-Specific Pten Deletion Protects against Insulin Resistance and Diabetes
Wijesekara, N., Konrad, D., Eweida, M., Jefferies, C., Liadis, N., Giacca, A., Crackower, M., Suzuki, A., Mak, T. W., Kahn, C. R., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1135-1145.2005 · Cited by 237
Cline, G. W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., Damico, C., & Shulman, G. I. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2903 · Cited by 228
Lochhead, P. A., Coghlan, M., Rice, S. Q. J., & Sutherland, C. (2001) · Diabetes · doi:10.2337/diabetes.50.5.937 · Cited by 219
Glycogen Synthase Kinase 3β Functions To Specify Gene-Specific, NF-κB-Dependent Transcription
Steinbrecher, K. A., Wilson, W., Cogswell, P. C., & Baldwin, A. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8444-8455.2005 · Cited by 205
Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Carter, L., Johnson, K., & Henry, R. R. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2190 · Cited by 198
Takada, Y., Fang, X., Jamaluddin, M. S., Boyd, D. D., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403449200 · Cited by 182
Shulman, G. I. (2004) · Physiology · doi:10.1152/physiol.00007.2004 · Cited by 178
Fang, X., Yu, S., Tanyi, J. L., Lu, Y., Woodgett, J. R., & Mills, G. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2099-2110.2002 · Cited by 173
Self-citationDiscovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes
Wagman, A., Johnson, K., & Bussiere, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452668 · Cited by 153 · cited 1×
“Indeed, young animals as well as mildly (but not severely) diabetic animal models show a greater responsiveness in lowering blood glucose when treated with GSK-3 inhibitors (47).”
BackgroundEldar-Finkelman, H., Argast, G. M., Foord, O., Fischer, E. H., & Krebs, E. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10228 · Cited by 152
Selective expression of Cre recombinase in skeletal muscle fibers
Bothe, G. W. M., Haspel, J. A., Smith, C. L., Wiener, H. H., & Burden, S. J. (2000) · genesis · doi:10.1002/(sici)1526-968x(200002)26:2<165::aid-gene22>3.0.co;2-f · Cited by 151
Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase
Wang, Q., Zhou, Y., Wang, X., & Evers, B. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209004 · Cited by 149
Metabolic and molecular basis of insulin resistance
Bajaj, M., & DeFronzo, R. A. (2003) · Journal of Nuclear Cardiology · doi:10.1016/s1071-3581(03)00520-8 · Cited by 131
Dokken, B. B., Sloniger, J. A., & Henriksen, E. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00547.2004 · Cited by 120
Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle
Bouskila, M., Hirshman, M. F., Jensen, J., Goodyear, L. J., & Sakamoto, K. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00481.2007 · Cited by 118
Tanabe, K., Liu, Z., Patel, S., Doble, B. W., Li, C., CRAS-MÉNEUR, C. M. H., Martinez, S. C., Welling, C. M., White, M. F., Bernal‐Mizrachi, E., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060037 · Cited by 118
Self-citationKaidanovich‐Beilin, O., & Eldar-Finkelman, H. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090266 · Cited by 113
Orena, S., Torchia, A. J., & Garofalo, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910002199 · Cited by 111
Pearce, N. J., Arch, J. R. S., Clapham, J. C., Coghlan, M. P., Corcoran, S. L., Lister, C. A., Llano, A., Moore, G. B. T., Murphy, G. J., Smith, S. A., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.008 · Cited by 111
Henriksen, E. J., Kinnick, T. R., Teachey, M. K., O'Keefe, M. P., Ring, D., Johnson, K. W., & Harrison, S. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00346.2002 · Cited by 108
Nikoulina, S. E., Ciaraldi, T. P., Carter, L., Mudaliar, S. R. D., Park, K. S., & Henry, R. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7872 · Cited by 67
MEKK4 Stimulation of p38 and JNK Activity Is Negatively Regulated by GSK3β
Abell, A. N., Granger, D. A., & Johnson, G. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705783200 · Cited by 66
MacAulay, K., Hajduch, É., Blair, A. S., Coghlan, M. P., Smith, S. A., & Hundal, H. S. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03777.x · Cited by 63
Self-citationTargeting glycogen synthase kinase-3 in insulin signalling
Frame, S., & Zheleva, D. I. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.3.429 · Cited by 62
Liu, S., Yu, S., Hasegawa, Y., LaPushin, R., Xu, H., Woodgett, J. R., Mills, G. B., & Fang, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408607200 · Cited by 53
Self-citationCheng, K., Creacy, S. D., & Larner, J. (1983) · Molecular and Cellular Biochemistry · doi:10.1007/bf00227219 · Cited by 49
Hansen, L., Arden, K. C., Rasmussen, S., Viars, C. S., Vestergaard, H., Hansen, T. F., Møller, A. M., Woodgett, J. R., & Pedersen, O. B. (1997) · Diabetologia · doi:10.1007/s001250050771 · Cited by 44
Self-citation
Cited by
Glycogen and its metabolism: some new developments and old themes
Roach, P. J., Depaoli-Roach, A. A., Hurley, T. D., & Tagliabracci, V. S. (2012) · Biochemical Journal · doi:10.1042/bj20111416 · Cited by 709
PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis
Schultze, S. M., Hemmings, B. A., Niessen, M., & Tschopp, O. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002109 · Cited by 540
Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., Pons, D. A., Owen, R. J., Satchell, S. C., Miles, M. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.08.015 · Cited by 462
GSK-3 is a master regulator of neural progenitor homeostasis
Kim, W.-Y., Wang, X., Wu, Y., Doble, B. W., Patel, S., Woodgett, J. R., & Snider, W. D. (2009) · Nature Neuroscience · doi:10.1038/nn.2408 · Cited by 399
Self-citationWang, L., Li, J., & Di, L. (2022) · Medicinal Research Reviews · doi:10.1002/med.21867 · Cited by 261
Metadata
- Authors
- Patel, S., Doble, B. W., MacAulay, K., Sinclair, E. M., Drucker, D. J., & Woodgett, J. R.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-10-01
- Volume
- 28
- Issue
- 20
- Pages
- 6314-6328
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2128282944
- Cited by
- 260
- References
- 55
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.